tvN's "Going to Work Tomorrow, Too!": Seo In-guk and Park Ji-hyun Face Unexpected Setbacks During Home AI Demo
Entire Task Force on Edge… Attention Focused on Whether There Was Deliberate Interference
Anxiety Mounts Over Lee Young-hoon’s Return and Background Checks on Jeon Ki-tae
Broadcast on tvN every Monday and Tuesday at 8:50 p.m.
[Edaily Reporter Son Eui-Yeon ] In the tvN Monday-Tuesday drama *Go to Work Tomorrow!*, Seo In-guk and Park Ji-hyun’s top-secret home AI project faces an unexpected crisis during its first public demonstration. In stills released ahead of episodes 9 and 10, the task force team—led by Kang Si-woo (played by Seo In-guk) and Cha Ji-yoon (played by Park Ji-hyun)—is shown unveiling the home AI project for the first time in front of overseas buyers. The presentation, which had been proceeding smoothly, encounters an unexpected setback, and Kang Si-woo and Cha Ji-yoon are unable to hide their bewilderment. Even the TF team members Jeon Gi-tae (played by Kang Gi-duong), Shin Na-ri (played by Lee Jae-i), and Yoon No-ah (played by Kang Mi-na) cannot hide their tension, heightening curiosity about the project’s fate.
In the previous episode, Lee Young-hoon (played by Yang Byung-yeol), who had been on leave, joined the task force and informed Executive Director Noh (played by Kim Hak-seon) of this. He then began exhibiting suspicious behavior, such as coming into the office on weekends under the pretext of work. Additionally, Jeon Ki-tae began investigating Kang Si-woo on the orders of Manager Ko (played by Hong Woo-jin), further heightening the sense of unease surrounding the TF team. Attention is now focused on whether this unexpected turn of events is a simple mistake or the result of someone’s deliberate intervention.
“Going to Work Tomorrow, Too!” is an office romance about Cha Ji-yoon, a seven-year office veteran, who rediscovers the thrill of both work and love alongside her prickly boss, Kang Si-woo.
IlyangPharmaceutical(007570)has finalized the liquidation process for Daebang Planning, a family-owned company of the controlling family. The company plans to completely eliminate risks associated wit…
SAMSUNG BIOLOGICS(207940)has signed the largest merger and acquisition (M&A) deal in South Korea’s pharmaceutical and biotech industry to produce peptide drugs, which are well known as ingredients in …
Key executives from Naver (NAVER(035420)), including Chairman Lee Hae-jin—the company’s founder—and CEO Choi Soo-yeon, are visiting Canada to meet with global alternative asset manager Brookfield and …